Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 13, 2018
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
[ Fri, Jul 13th 2018
] - WOPRAI
Thu, July 12, 2018
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
Edward White Initiated (SNDX) at Strong Buy and Held Target at $30 on, Jul 12th, 2018
Edward White of HC Wainwright & Co., Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $30 on, Jul 12th, 2018.
Edward has made no other calls on SNDX in the last 4 months.
There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $24 on, Wednesday, March 14th, 2018
Similar Stocks and Investing Articles
[ Wed, Jun 20th 2018
] - WOPRAI
[ Fri, Jun 15th 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Fri, Jan 26th 2018
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI
[ Tue, Feb 24th 2015
] - WOPRAI
[ Tue, May 14th 2013
] - WOPRAI
[ Fri, Mar 15th 2013
] - WOPRAI
[ Fri, Jul 27th 2012
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI